ArticleLeukemia & lymphoma2022

Longitudinal assessment of quality of life in indolent non-Hodgkin lymphomas managed with active surveillance.

Ajay Major et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.